Delivery Order SPE2DB22D1106-SPE2DB25FFAC7
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $77K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gilenya 0.5 mg capsules (30-count units) with a ceiling value of $20,252.06. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,630.00 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (quantity: 30 units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,597.07, is for the supply of Gilenya 0.5 mg capsules. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,019.86, is for the delivery of Gilenya 0.5 mg capsules with an ultimate completion date of April 29, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,952.07 firm fixed price contract is for the supply of Gilenya 0.5 mg capsules, a specialty medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 13, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,852.32, is for the supply of Gilenya 0.5 mg capsules. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 30-count capsules of the drug Gilenya 0.5 mg. The contract has a firm fixed price of $9,019.86 and a period of performance through July 10, 2025. The contract is not designated as a set-aside and was awarded on July 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order, valued at $20,129.07, has a completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation. In addition to this specific award, Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Gilenya 0.5 mg capsule 30s, with a ceiling value of $48,930.98 and a completion date of June 9, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...